Moderna Announces That Its MRNA-1403 Norovirus Vaccine Candidate Did Not Meet Statistical Criteria For Early Success At Phase 3 Interim Analysis; Now Preparing To Enroll An Additional Cohort

Benzinga Newsdesk www.benzinga.com Neutral 59.4%

Neg 0% Neu 59.4% Pos 0%

Comments

No comments yet. Be the first!